Boston Scientific announced today that it agreed to acquire Axonics (Nasdaq:AXNX) in a deal worth approximately $3.7 billion. Shares of AXNX skyrocketed before the market opened today, rising 21.1% to $69.72 apiece. Shares of BSX stayed even. Marlborough, Massachusetts-based Boston Scientific priced the acquisition at $71 in cash per share. It amounts to an equity […]
Boston Scientific
Boston Scientific initiates new Farapulse trial, expects FDA approval in 2024
Boston Scientific announced today that it initiated the AVANT GUARD clinical trial to evaluate its Farapulse pulsed field ablation (PFA) system. The company also says it now anticipates FDA approval for Farapulse in the first quarter of 2024. AVANT GUARD looks at the safety and effectiveness of Farapulse as a first-line treatment for persistent AFib. […]
The top medtech trends of 2023
The top medtech trends of 2023 included innovations such as artificial intelligence, new GLP-1 weight loss drugs and some long-awaited medtech finally receiving regulatory nods. With health providers facing additional challenges on top of an ever-uncertain economic environment, medtech companies also made major readjustments: layoffs, spinoffs, reorganizations and much more. Here are the top stories […]
Medtronic PulseSelect pulsed field ablation wins FDA approval
The FDA has approved the Medtronic PulseSelect pulsed field ablation (PFA) system, the device developer said today. PulseSelect is the first PFA technology approved for use in the U.S., as well as the first PFA technology with FDA breakthrough designation to win approval. The minimally invasive, cardiac ablation system is indicated for the treatment of […]
‘A safe pair of hands’ — Medtech’s investment in Ireland continues to grow
Medtech established its presence in Ireland many years ago and still, companies continue to invest in the ever-growing country. Boston Scientific established operations in Ireland in 1994, while Abbott has more than 70 years in the country. Medtronic, now officially headquartered in Dublin, has spent more than 40 years in Ireland and even hosted its […]
Boston Scientific closes Relievant Medsystems acquisition
Boston Scientific announced today that it completed its previously announced acquisition of Relievant Medsystems. In September, Boston Scientific announced plans to acquire Relievant for an upfront cash payment of $850 million. Additional payments are contingent on sales performance over the next three years. Minneapolis-based Relievant developed and commercialized the Intracept intraosseous nerve ablation system for […]
Boston Scientific wins FDA approval for penile prosthesis pump
Boston Scientific announced that the FDA granted approval for its Tenacio pump component for its AMS 700 inflatable penile prosthesis (IPP). The AMS 700 IPP offers a treatment option for patients with erectile dysfunction. It features three parts. The system has a pair of cylinders implanted in the penis, a pump placed in the scrotum […]
Boston Scientific has more positive Farapulse pulsed-field ablation data
Researchers shared positive data from a large, real-world registry of patients treated with the Boston Scientific Farapulse system. Data from more than 17,000 patients in the MANIFEST 17K registry reinforced the real-world safety profile for the pulsed-field ablation (PFA) system. Results included no reports of permanent phrenic nerve palsy, pulmonary vein stenosis or esophageal injury. […]
Boston Scientific shares positive drug-coated balloon data
Boston Scientific announced positive data from a trial of its Agent drug-coated balloon (DCB). The Marlborough, Massachusetts-based company presented its results at the Transcatheter Cardiovascular Therapeutics (TCT) meeting. Data demonstrated statistical superiority for Agent compared to uncoated balloon angioplasty. AGENT IDE evaluated the safety and effectiveness of using a DCB to treat coronary in-stent restenosis […]
The biggest cardiovascular stories from TCT 2023
Every year, some of the biggest names in cardiovascular technologies come together in one place for TCT. This year’s 35th edition of the Transcatheter Cardiovascular Therapeutics annual scientific symposium was no different in San Francisco. Usual suspects like Medtronic and Abbott released data covering a range of products, while other big names like Edwards, GE […]
Boston Scientific stock rises on Street-beating Q3, raised EPS guidance
Boston Scientific shares ticked up today on third-quarter results that came in ahead of the consensus forecast. Shares of BSX were up slightly at $50.44 apiece by midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies —was down more than 1%. Truist analysts described the results […]